REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Claret Arino Garcia Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Claret Arino Garcia Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Claret Arino Garcia Sas is a company based in Colombia, with its head office in Valledupar. It operates in the Diagnostic Imaging Centers industry. Laboratorio Clinico Claret Arino Garcia Sas was incorporated on July 26, 2012. It currently has a total number of 12 (2017) employees. The latest financial highlights indicate a net sales revenue drop of 38.32% in 2023. Its’ total assets recorded a negative growth of 20.7%. The net profit margin of Laboratorio Clinico Claret Arino Garcia Sas decreased by 2.14% in 2023.

Headquarters
Cr 18 14 85 Brr Alfonso Lopez
Valledupar; Cesar;

Contact Details: Purchase the Laboratorio Clinico Claret Arino Garcia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Clinico Claret Arino Garcia Sas report to view the information.
Outstanding Shares:
Purchase the Laboratorio Clinico Claret Arino Garcia Sas report to view the information.
Incorporation Date:
July 26, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Claret Arino Garcia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-38.32%
Total operating revenue
-38.32%
Operating profit (EBIT)
-17.26%
EBITDA
-18.52%
Net Profit (Loss) for the Period
-52.56%
Total assets
-20.7%
Total equity
6.12%
Operating Profit Margin (ROS)
5.59%
Net Profit Margin
-2.14%
Return on Equity (ROE)
-9.24%
Debt to Equity Ratio
-71.51%
Quick Ratio
0.3%
Cash Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?